{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T13:19:17Z","timestamp":1717420757305},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2008,11,7]],"date-time":"2008-11-07T00:00:00Z","timestamp":1226016000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1007\/s00105-008-1552-9","type":"journal-article","created":{"date-parts":[[2008,11,5]],"date-time":"2008-11-05T15:45:41Z","timestamp":1225899941000},"page":"986-991","source":"Crossref","is-referenced-by-count":4,"title":["Terbinafin-Topika"],"prefix":"10.1007","volume":"59","author":[{"given":"M.-H.","family":"Schmid-Wendtner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Korting","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,11,7]]},"reference":[{"key":"1552_CR1","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1468-3083.1999.tb00908.x","volume":"12","author":"Haneke","year":"1999","unstructured":"Haneke E (1999) Achilles foot-screening project: background, objectives, and design. J Eur Acad Dermatol Venereol 12 (Suppl 1): 2\u20135","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1552_CR2","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1046\/j.0933-7407.2003.00933.x","volume":"46","author":"Burzykowski","year":"2003","unstructured":"Burzykowski T, Molenberghs G, Abeck D et al. (2003) High prevalence of foot disease in Europe: results of the Achilles Project. Mycases 46: 496\u2013505","journal-title":"Mycases"},{"key":"1552_CR3","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1159\/000080853","volume":"209","author":"Roujeau","year":"2004","unstructured":"Roujeau JC, Sigurgeirsson B, Korting HC et al. (2004) Chronic dermatomycoses of the foot as risk factors for acute bacterial cellulitis of the leg: a case-control study. Dermatology 209: 301\u2013307","journal-title":"Dermatology"},{"key":"1552_CR4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0190-9622(08)81262-5","volume":"31","author":"Aly","year":"1994","unstructured":"Aly R (1994) Ecology and epidemiology of dermatophyte infections. J Am Acad Dermatol 31: 21\u201325","journal-title":"J Am Acad Dermatol"},{"key":"1552_CR5","doi-asserted-by":"crossref","unstructured":"Haneke E, Nolting S, Seebacher C et al. (2000) Neue Erkenntnisse zur Epidemiologie von Fu\u00dferkrankungen. In: Plettenberg A, Meigel WN, Moll I (Hrsg) Dermatologie an der Schwelle zum neuen Jahrtausend. Springer, Berlin Heidelberg New York, S\u00a0377\u2013378","DOI":"10.1007\/978-3-642-57191-6_101"},{"key":"1552_CR6","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1055\/s-2003-41969","volume":"128","author":"Korting","year":"2003","unstructured":"Korting HC, Rychlik R, Pfeil B (2003) Behandlung der Tinea pedis vom interdigitalen Typ. Systematischer Review. Dtsch Med Wochenschr 128: 1819\u20131824","journal-title":"Dtsch Med Wochenschr"},{"key":"1552_CR7","unstructured":"Seebacher C, Abeck D, Barsch J et al. (2005) Tinea der freien Haut. In: Korting HC, Callies R, Reusch M, Schlaeger M, Sterry W (Hrsg) Dermatologische Qualit\u00e4tssicherung, Leitlinien und Empfehlungen, 4.\u00a0Aufl. ABW Wissenschaftsverlag, Berlin, S\u00a0117\u2013123"},{"key":"1552_CR8","unstructured":"Fricke U (2002) Antimykotika. In: Schwabe U, Paffrath D (Hrsg) Arzneimittelverordnungsreport 2001. Springer, Berlin Heidelberg New York, S\u00a0221\u2013236"},{"key":"1552_CR9","unstructured":"Schmid-Wendtner MH (2006) Terbinafin \u2013 Systemische und topische Therapie von Pilzinfektionen. In: Sch\u00e4fer-Korting M (Hrsg) The critical drug monograph. ABW Wissenschaftsverlag, Berlin"},{"key":"1552_CR10","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1185\/030079907X199664","volume":"23","author":"Kienzler","year":"2007","unstructured":"Kienzler JL, Queille-Roussel C, Mugglestone C et al. (2007) Stratum corneum pharmaco-kinetics of the antifungal drug terbinafine in a novel topical formulation for single-dose application in dermatophytoses. Curr Med Res Opin 23: 1293\u20131302","journal-title":"Curr Med Res Opin"},{"key":"1552_CR11","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1136\/bmj.319.7202.79","volume":"319","author":"Hart","year":"1999","unstructured":"Hart R, Bell-Syer EM, Crawford R et al. (1999) Systematic review of topical treatments for fungal infections of the skin and nails of the feet. BMJ 319: 79\u201382","journal-title":"BMJ"},{"key":"1552_CR12","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1055\/s-2004-814541","volume":"30","author":"Korting","year":"2004","unstructured":"Korting HC, Kresimon J, Rychlik R (2004) Vergleichende Bewertung der Wirkung und klinischen Wirksamkeit von terbinafinhaltigen und bifonazolhaltigen Topika bei der Behandlung der Fu\u00dfmykose. Akt Dermatol 30: 210\u2013217","journal-title":"Akt Dermatol"},{"key":"1552_CR13","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2165\/00128071-200708060-00005","volume":"8","author":"Korting","year":"2007","unstructured":"Korting HC, Kienke P, Nelles S et al. (2007) Comparable efficacy and safety of various topical formulations of terbinafine in tinea pedis irrespective of the treatment regimen. Am J Clin Dermatol 8: 357\u2013364","journal-title":"Am J Clin Dermatol"},{"key":"1552_CR14","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/0190-9622(90)70289-T","volume":"23","author":"Savin","year":"1990","unstructured":"Savin RC (1990) Treatment of chronic tinea pedis (athlete\u201as foot type) with topical terbinafine. J Am Acad Dermatol 23: 786\u2013789","journal-title":"J Am Acad Dermatol"},{"key":"1552_CR15","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/0190-9622(90)70290-X","volume":"23","author":"Smith","year":"1990","unstructured":"Smith EB, Noppakun N, Newton RC (1990) A clinical trial report of topical terbinafine (a new allylamine antifungal) in the treatment of tinea pedis. J Am Acad Dermatol 23: 790\u2013794","journal-title":"J Am Acad Dermatol"},{"key":"1552_CR16","doi-asserted-by":"crossref","unstructured":"Evans EGV, James IGV, Joshipura RC () Two-week treatment of tinea pedis with terbinafine (Lamisil) 1% cream: a placebo controlled study. J Dermatol Treatm 2: 95\u201397","DOI":"10.3109\/09546639109092729"},{"key":"1552_CR17","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/0190-9622(92)70141-2","volume":"26","author":"Berman","year":"1992","unstructured":"Berman B, Ellis C, Leyden J et al. (1992) Efficacy of a 1-week, twice daily regimen of terbinafine 1% cream in the treatment of interdigital tinea pedis. J Am Acad Dermatol 26: 956\u2013960","journal-title":"J Am Acad Dermatol"},{"key":"1552_CR18","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0190-9622(09)80122-9","volume":"30","author":"Savin","year":"1994","unstructured":"Savin R, Atton SV, Bergstresser PR et al. (1994) Efficacy of terbinafine 1% cream in the treatment of moccasin-type tinea pedis: results of placebo-controlled multicenter trials. J Am Acad Dermatol 30: 663\u2013667","journal-title":"J Am Acad Dermatol"},{"key":"1552_CR19","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/mmy.39.4.335.340","volume":"39","author":"Korting","year":"2001","unstructured":"Korting HC, Tietz HJ, Br\u00e4utigam M et al. (2001) One week terbinafine 1% cream (Lamisil\u00ae) once daily is effective in the treatment of interdigital tinea pedis: a vehicle controlled study. Med Mycol 39: 335\u2013340","journal-title":"Med Mycol"},{"key":"1552_CR20","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1046\/j.1468-3083.2002.368_6.x","volume":"16","author":"Hollmen","year":"2002","unstructured":"Hollmen KA, Kinnunen T, Kiistala U et al. (2002) Efficacy and tolerability of terbinafine 1% emulsion gel in patients with tinea pedis. Eur Acad Dermatol Venereol 16: 81\u201394","journal-title":"Eur Acad Dermatol Venereol"},{"key":"1552_CR21","first-page":"1","volume":"51","author":"Feuilhade","year":"2007","unstructured":"Feuilhade de Chauvin M, Viguie-Vallanet C, Kienzler JL et al. (2007) Novel, single-dose, topical treatment of tinea pedis using terbinafine: results of a dose-finding clinical trial. Mycoses 51: 1\u20136","journal-title":"Mycoses"},{"key":"1552_CR22","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1111\/j.1468-3083.2006.01807.x","volume":"20","author":"Ortonne","year":"2006","unstructured":"Ortonne JP, Korting HC, Viguie-Vallanet C et al. (2006) Efficacy and safety of a new single-dose terbinafine 1% formulation in patients with tinea pedis (athlete\u2019s foot): a randomised, double-blind, placebo-controlled study. J Eur Acad Dermatol Venereol 20: 1307\u20131313","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1552_CR23","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/09546630701247971","volume":"18","author":"James","year":"2007","unstructured":"James IG, Loria-Kanza Y, Jones TC (2007) Short-duration topical treatment of tinea pedis using terbinafine emulsion gel: results of a dose-ranging clinical trial. J Dermatolog Treat 18: 163\u2013168","journal-title":"J Dermatolog Treat"},{"key":"1552_CR24","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S0190-9622(08)81787-2","volume":"28","author":"Bergstresser","year":"1993","unstructured":"Bergstresser ER, Elewski B, Hanafin JM et al. (1993) Topical terbinafine and clotrimazole in interdigital tinea pedis: a multicenter comparison of cure and relapse rates with 1- and 4-week treatment regimens. J Am Acad Dermatol 28: 648\u2013651","journal-title":"J Am Acad Dermatol"},{"key":"1552_CR25","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1136\/bmj.307.6905.645","volume":"307","author":"Evans","year":"1993","unstructured":"Evans EGV, Dodman B, Williamson DM et al. (1993) Comparison of terbinafine and clotrimazole in treating tinea pedis. BMJ 307: 645\u2013647","journal-title":"BMJ"},{"key":"1552_CR26","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1046\/j.1439-0507.1999.00477.x","volume":"42","author":"Schopf","year":"1999","unstructured":"Schopf R, Hettler O, Br\u00e4utigam M et al. (1999) Efficacy and tolerability of terbinafine 1% topical solution used for 1 week compared with 4 weeks clotrimazole 1% topical solution in the treatment of interdigital tinea pedis: a randomized, double-blind, multi-centre, 8-week clinical trial. Mycoses 42: 415\u2013420","journal-title":"Mycoses"},{"key":"1552_CR27","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1046\/j.1440-0960.1999.00360.x","volume":"40","author":"Patel","year":"1999","unstructured":"Patel A, Brookman SD, Bullen MU et al. (1999) Topical treatment of interdigital tinea pedis: terbinafine compared with clotrimazole. Australas J Dermatol 40: 197\u2013200","journal-title":"Australas J Dermatol"},{"key":"1552_CR28","first-page":"1605","volume":"31","author":"Vermeer","year":"1996","unstructured":"Vermeer BJ, Staats CCG, van Houvelingen JC (1996) Terbinafine versus miconazol bij patienten met tinea pedis. Ned Tijdschr Geneeskd 31: 1605\u20131608","journal-title":"Ned Tijdschr Geneeskd"},{"key":"1552_CR29","first-page":"1006","volume":"82","author":"Leenutaphong","year":"1999","unstructured":"Leenutaphong V, Tangwiwat S, Muanprasat C et al. (1999) Double-blind study of the efficacy of 1 week topical terbinafine cream compared to 4 weeks miconazole cream in patients with tinea pedis. J Med Assoc Thai 82: 1006\u20131010","journal-title":"J Med Assoc Thai"},{"key":"1552_CR30","unstructured":"Sanchez Carazo JL, Fuente C, Oliver V et al. (1994) Estudia comparativo de terbinafina vs. bifonazol crema al 1% en aplicacion unica diaria en tinea pedis. Actas Dermo-Sif 85: 388\u2013394"},{"key":"1552_CR31","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3109\/09546639709160526","volume":"8","author":"Wahid","year":"1997","unstructured":"Wahid Z, Butt J, Nishtar R (1997) Multicentre double-blind study of efficacy and safety of terbinafine 1% cream compared with bifonazole 1% cream in patients with tinea pedis moccasin type. J Dermatol Treatm 8: 225\u2013227","journal-title":"J Dermatol Treatm"},{"key":"1552_CR32","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2165\/00044011-200019060-00001","volume":"19","author":"Syed","year":"2000","unstructured":"Syed TA, Hadi SM, Qureshi ZA et al. (2000) Butenafine 1% versus terbinafine 1% cream for the treatment of tinea pedis: a placebo-controlled, double-blind, comparative study. Clin Drug Invest 19: 393\u2013397","journal-title":"Clin Drug Invest"},{"key":"1552_CR33","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1365-4362.1996.tb03668.x","volume":"5","author":"Ablon","year":"1996","unstructured":"Ablon G, Rosen T, Spedale J (1996) Comparative efficacy of naftifine, oxiconazole, and terbinafine in short-term treatment of tinea pedis. Int J Dermatol 5: 591\u2013593","journal-title":"Int J Dermatol"},{"key":"1552_CR34","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/j.1468-3083.2007.02364.x","volume":"21","author":"Schmid-Wendtner","year":"2007","unstructured":"Schmid-Wendtner MH, Korting HC (2007) Effective treatment for dermatophytoses of the foot: effect on restoration of depressed cell-mediated immunity. J Eur Acad Dermatol Venereol 21: 1013\u20131018","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-008-1552-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-008-1552-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-008-1552-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T23:37:38Z","timestamp":1558568258000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-008-1552-9"}},"subtitle":["Ultimative Verk\u00fcrzung der Therapiedauer bei Tinea pedis"],"short-title":[],"issued":{"date-parts":[[2008,11,7]]},"references-count":34,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["1552"],"URL":"https:\/\/doi.org\/10.1007\/s00105-008-1552-9","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11,7]]}}}